ICUI.NASDAQIcu Medical Inc/de

Form 4: ICU Medical Inc. CEO Vivek Jain Reports Stock Transactions

Sentiment:

SEC Filing

📋All filings for Icu Medical Inc/de
🔒Login to Follow

Vivek Jain, Chairman and CEO of ICU Medical Inc., reports the acquisition and disposal of common stock and derivative securities related to restricted stock units.

Summary

  • Vivek Jain, the Chairman and CEO of ICU Medical Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 15, 2024, Jain acquired 4,871 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.00.
  • Also on March 15, 2024, Jain disposed of 2,671 shares of common stock at a price of $98.08.
  • Following these transactions, Jain directly owns 104,593 shares of common stock and indirectly owns 88,698 shares through a trust.
  • Jain also reports ownership of 9,744 derivative securities related to common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in the CEO's stock ownership.

Key Dates

DateDescription
03/15/2023Date the restricted stock units were legally granted.
05/17/2023Date the restricted stock units were subject to shareholder approval.
03/15/2024Date of the reported transactions: acquisition and disposal of common stock.
03/15/2026Expiration date of the derivative security.
03/18/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.